glycine has been researched along with Hyperkalemia in 11 studies
Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Intraventricular conduction disorders and reentrant arrhythmias in dogs can be produced by high plasma bupivacaine concentrations." | 7.68 | Enhancement by hyponatremia and hyperkalemia of ventricular conduction and rhythm disorders caused by bupivacaine. ( Bertix, L; Couzon, P; Faucon, G; Freysz, M; Mazze, R; Timour, Q, 1990) |
| " Additional data are needed regarding the effectiveness and safety of roxadustat as compared with standard therapy (epoetin alfa) for the treatment of anemia in patients undergoing dialysis." | 5.30 | Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis. ( Cai, GY; Chen, N; Hao, C; Hao, L; Jiang, G; Leong, R; Li, X; Liang, X; Lin, H; Liu, BC; Liu, C; Liu, Z; Luo, L; Neff, T; Szczech, L; Wang, C; Wang, J; Xing, C; Yu, KP; Zhao, MH; Zuo, L, 2019) |
| "Glyphosate potassium poisoning causes hyperkalemia." | 3.91 | Serial measurement of glyphosate blood concentration in a glyphosate potassium herbicide-intoxicated patient: A case report. ( Ahn, H; Cho, S; Cho, Y; Choi, H; Jeong, W; Kim, S; Min, J; Oh, S; Park, J; You, Y, 2019) |
| "Ingestion of glyphosate-surfactant herbicides (GlySH) can result in acute kidney injury, electrolyte abnormalities, acidosis, cardiovascular collapse, and death." | 3.80 | Hemodialysis clearance of glyphosate following a life-threatening ingestion of glyphosate-surfactant herbicide. ( Allan, MJ; Garlich, FM; Goldfarb, DS; Goldman, M; Goldstein, DA; Hoffman, RS; Nelson, LS; Pepe, J, 2014) |
| "Intraventricular conduction disorders and reentrant arrhythmias in dogs can be produced by high plasma bupivacaine concentrations." | 3.68 | Enhancement by hyponatremia and hyperkalemia of ventricular conduction and rhythm disorders caused by bupivacaine. ( Bertix, L; Couzon, P; Faucon, G; Freysz, M; Mazze, R; Timour, Q, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 8 (72.73) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, Y | 1 |
| Jeong, W | 1 |
| Kim, S | 1 |
| Choi, H | 1 |
| You, Y | 1 |
| Cho, S | 1 |
| Oh, S | 1 |
| Ahn, H | 1 |
| Park, J | 1 |
| Min, J | 1 |
| Chen, N | 2 |
| Hao, C | 2 |
| Peng, X | 1 |
| Lin, H | 2 |
| Yin, A | 1 |
| Hao, L | 2 |
| Tao, Y | 1 |
| Liang, X | 2 |
| Liu, Z | 3 |
| Xing, C | 2 |
| Chen, J | 1 |
| Luo, L | 2 |
| Zuo, L | 2 |
| Liao, Y | 1 |
| Liu, BC | 2 |
| Leong, R | 2 |
| Wang, C | 3 |
| Liu, C | 2 |
| Neff, T | 2 |
| Szczech, L | 2 |
| Yu, KP | 2 |
| Jiang, G | 1 |
| Li, X | 1 |
| Wang, J | 1 |
| Zhao, MH | 1 |
| Cai, GY | 1 |
| Garlich, FM | 1 |
| Goldman, M | 1 |
| Pepe, J | 1 |
| Nelson, LS | 1 |
| Allan, MJ | 1 |
| Goldstein, DA | 1 |
| Goldfarb, DS | 1 |
| Hoffman, RS | 1 |
| Kato, Y | 1 |
| Bando, H | 1 |
| Murao, Y | 1 |
| Aoyagi, U | 1 |
| Hirakawa, A | 1 |
| Iwase, M | 1 |
| Nakatani, T | 1 |
| Kamijo, Y | 1 |
| Mekari, M | 1 |
| Yoshimura, K | 1 |
| Kan'o, T | 1 |
| Soma, K | 1 |
| Zouaoui, K | 1 |
| Dulaurent, S | 1 |
| Gaulier, JM | 1 |
| Moesch, C | 1 |
| Lachâtre, G | 1 |
| Stella, J | 1 |
| Ryan, M | 1 |
| Hahn, RG | 1 |
| Timour, Q | 1 |
| Freysz, M | 1 |
| Mazze, R | 1 |
| Couzon, P | 1 |
| Bertix, L | 1 |
| Faucon, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease Not on Dialysis[NCT02652819] | Phase 3 | 154 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| A Randomized Controlled Trial to Evaluate the Safety and Efficacy of Roxadustat in Patients With Acute ST Elevation Myocardial Infarction[NCT04803864] | Phase 2 | 158 participants (Anticipated) | Interventional | 2021-06-10 | Recruiting | ||
| Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study[NCT05010460] | Phase 2 | 318 participants (Anticipated) | Interventional | 2021-09-30 | Recruiting | ||
| Roxadustat Combined With Luspatercept Versus Luspatercept Monotherapy in the Treatment of Refractory Myelodysplastic Syndrome With Ring Sideroblasts (MDS-RS): A Prospective Randomized Controlled Study[NCT06006949] | Phase 4 | 62 participants (Anticipated) | Interventional | 2023-08-31 | Not yet recruiting | ||
| A Phase 3, Randomized, Open-Label, Active-Controlled Study of Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Chronic Kidney Disease on Dialysis[NCT02652806] | Phase 3 | 305 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for glycine and Hyperkalemia
| Article | Year |
|---|---|
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.
Topics: Acidosis; Adult; Aged; Anemia; Cholesterol; Double-Blind Method; Female; Glycine; Hematinics; Hemogl | 2019 |
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Topics: Adult; Aged; Analysis of Variance; Anemia; Cholesterol; Double-Blind Method; Epoetin Alfa; Female; G | 2019 |
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Topics: Adult; Aged; Analysis of Variance; Anemia; Cholesterol; Double-Blind Method; Epoetin Alfa; Female; G | 2019 |
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Topics: Adult; Aged; Analysis of Variance; Anemia; Cholesterol; Double-Blind Method; Epoetin Alfa; Female; G | 2019 |
Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.
Topics: Adult; Aged; Analysis of Variance; Anemia; Cholesterol; Double-Blind Method; Epoetin Alfa; Female; G | 2019 |
9 other studies available for glycine and Hyperkalemia
| Article | Year |
|---|---|
Serial measurement of glyphosate blood concentration in a glyphosate potassium herbicide-intoxicated patient: A case report.
Topics: Aged; Arrhythmias, Cardiac; Glycine; Glyphosate; Herbicides; Humans; Hyperkalemia; Male; Nausea; Pot | 2019 |
Hemodialysis clearance of glyphosate following a life-threatening ingestion of glyphosate-surfactant herbicide.
Topics: Acidosis; Blood Chemical Analysis; Electrocardiography; Glycine; Glyphosate; Hemodynamics; Herbicide | 2014 |
[Three cases of an extreme hyperkalemia associated with glyphosate potassium herbicide poisoning].
Topics: Acute Kidney Injury; Adult; Aged; Calcium Gluconate; Female; Glycine; Glyphosate; Herbicides; Humans | 2015 |
[Extreme hyperkalemia in a patient with a new glyphosate potassium herbicide poisoning: report of a case].
Topics: Aged; Female; Glycine; Glyphosate; Herbicides; Humans; Hyperkalemia; Potassium; Severity of Illness | 2010 |
Glyphosate-surfactant herbicide products containing glyphosate potassium salt can cause fatal hyperkalemia if ingested in massive amounts.
Topics: Aged; Electrocardiography; Female; Glycine; Glyphosate; Herbicides; Humans; Hyperkalemia; Surface-Ac | 2012 |
Determination of glyphosate and AMPA in blood and urine from humans: about 13 cases of acute intoxication.
Topics: Accidents; Acidosis; Adult; Aged; Arrhythmias, Cardiac; Chemical and Drug Induced Liver Injury; Chro | 2013 |
Glyphosate herbicide formulation: a potentially lethal ingestion.
Topics: Acidosis; Administration, Oral; Adult; Aged; Drug Overdose; Emergency Medicine; Fatal Outcome; Glyci | 2004 |
Hyperkalemia from nonelectrolyte solutions.
Topics: Animals; Electrolytes; Glycine; Humans; Hyperkalemia; Isotonic Solutions; Male; Mannitol; Potassium; | 1993 |
Enhancement by hyponatremia and hyperkalemia of ventricular conduction and rhythm disorders caused by bupivacaine.
Topics: Animals; Arrhythmias, Cardiac; Bupivacaine; Dogs; Electrocardiography; Female; Glycine; Heart Conduc | 1990 |